Pillstats
Rx only · Injection · Intravenous

Vasopressin

Brands: Vasostrict · Vasopressin

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)11149
US makers9 labelers
Packages26
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3256509751.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
685
Rx · 2026 Q1
1.7K
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Par Health USA, LLCunknown6SUPPLYING
Medical Purchasing Solutions, LLCunknown4SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown4SUPPLYING
Eugia US LLCunknown3SUPPLYING
Amneal Pharmaceuticals LLCunknown3SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING
Amphastar Pharmaceuticals, Inc.unknown1SUPPLYING
ProPharma Distributionunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 11, 2024
    RECALLRecall (Class II): Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vial…

    Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit. — Recalling firm: Par Sterile Products LLC — Nationwide USA